<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126159">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02027974</url>
  </required_header>
  <id_info>
    <org_study_id>13-1-M-239</org_study_id>
    <nct_id>NCT02027974</nct_id>
  </id_info>
  <brief_title>Post-Market Study of the ICONACY Hip System</brief_title>
  <official_title>ICONACY Hip Clinical Data Acquisition (13-1-M-239)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Iconacy Orthopedic Implants, LLC.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Iconacy Orthopedic Implants, LLC.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the use and efficacy of the Iconacy Hip System for
      total hip replacement surgery.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Radiographic success</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Harris Hip Score must be &gt; or = 80 at 2 years</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxford Hip Score &gt; 40 points at 2 years</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction at 1, 2, and 3 years</measure>
    <time_frame>1, 2, and 3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in Harris Hip Score from pre-surgery to 1, 2, and 3 years</measure>
    <time_frame>1, 2, and 3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvements in Oxford Hip Score from pre-survey to 1, 2, and 3 years</measure>
    <time_frame>1, 2, and 3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Degenerative Joint Disease</condition>
  <arm_group>
    <arm_group_label>Iconacy Hip System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Iconacy hip system prosthesis components</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stryker Accolade Hip System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stryker Accolade hip system prosthesis components</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Iconacy Hip System</intervention_name>
    <description>Comparison of Iconacy I-Hip system to the Stryker Accolade hip system using a randomized study.</description>
    <arm_group_label>Iconacy Hip System</arm_group_label>
    <other_name>Iconacy I-Hip</other_name>
    <other_name>I-Hip</other_name>
    <other_name>iHip</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Stryker Accolade Hip System</intervention_name>
    <description>Comparison of Iconacy I-Hip system to the Stryker Accolade hip system using a randomized study.</description>
    <arm_group_label>Stryker Accolade Hip System</arm_group_label>
    <other_name>Accolade</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  This must be a primary hip replacement on this hip

          -  Patient is 30 years of age or older

          -  Have hip joint disease related to one or more of the following: degenerative joint
             disease, including osteoarthritis or traumatic arthritis

          -  Patient is likely to be available for evaluation for the duration of the study

          -  Able and willing to sign the informed consent and follow study procedures

        Exclusion Criteria:

          -  Is younger than 30 years of age

          -  If there has been a total hip replacement on this hip in the past (no revisions
             allowed in study)

          -  Infection, or history of infection, acute or chronic, local or systemic

          -  Alcoholism or other addictions

          -  Muscular, neurological or vascular deficiencies which compromise the affected
             extremity

          -  Obesity(BMI&gt;45)

          -  Insufficient bone quality

          -  Loss of ligamentous structures

          -  High levels of physical activity

          -  Materials sensitivity

          -  Prisoner

          -  Mental conditions that may interfere with the patient's ability to give an informed
             consent or willingness to fulfill the study requirements

          -  Patient is pregnant

          -  Is not able to read English language
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>William A Hodge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eastern Maine Medical Center</affiliation>
  </overall_official>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 12, 2014</lastchanged_date>
  <firstreceived_date>January 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hip</keyword>
  <keyword>Arthroplasty</keyword>
  <keyword>Arthroplasties</keyword>
  <keyword>Prosthesis</keyword>
  <keyword>Iconacy</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Arthritis</keyword>
  <keyword>THA</keyword>
  <keyword>THR</keyword>
  <keyword>DJD</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Joint Diseases</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
